Farley J. Abad

Array ( [id] => 1234537 [patent_doc_number] => 06689367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences' [patent_app_type] => B1 [patent_app_number] => 09/291894 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 78665 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689367.pdf [firstpage_image] =>[orig_patent_app_number] => 09291894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1130877 [patent_doc_number] => 06787520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Inactivating process for lipid envelopped virus, and new antivirus lipopeptides' [patent_app_type] => B2 [patent_app_number] => 09/242343 [patent_app_country] => US [patent_app_date] => 1999-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7173 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787520.pdf [firstpage_image] =>[orig_patent_app_number] => 09242343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068662 [patent_doc_number] => 06844188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Methods and modified cells for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 09/288837 [patent_app_country] => US [patent_app_date] => 1999-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10846 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844188.pdf [firstpage_image] =>[orig_patent_app_number] => 09288837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234521 [patent_doc_number] => 06689363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions' [patent_app_type] => B1 [patent_app_number] => 09/239043 [patent_app_country] => US [patent_app_date] => 1999-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 56987 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689363.pdf [firstpage_image] =>[orig_patent_app_number] => 09239043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720817 [patent_doc_number] => 20030054505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'RECOMBINANT RSV EXPRESSION SYSTEMS AND VACCINES' [patent_app_type] => new [patent_app_number] => 09/161122 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20605 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054505.pdf [firstpage_image] =>[orig_patent_app_number] => 09161122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6342004 [patent_doc_number] => 20020034732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL DRUG SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL DRUG SCREENING' [patent_app_type] => new [patent_app_number] => 09/126559 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29045 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034732.pdf [firstpage_image] =>[orig_patent_app_number] => 09126559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733472 [patent_doc_number] => 07038035 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Vaccine-induced hepatitis B viral strain and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/719533 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9383 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038035.pdf [firstpage_image] =>[orig_patent_app_number] => 09719533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 693904 [patent_doc_number] => 07070790 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines' [patent_app_type] => utility [patent_app_number] => 09/084691 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 135 [patent_figures_cnt] => 135 [patent_no_of_words] => 24342 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070790.pdf [firstpage_image] =>[orig_patent_app_number] => 09084691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773836 [patent_doc_number] => 20030017174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'HERPES SIMPLEX VIRUS VP22 VACCINES AND METHODS OF USE' [patent_app_type] => new [patent_app_number] => 09/084669 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19864 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017174.pdf [firstpage_image] =>[orig_patent_app_number] => 09084669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147506 [patent_doc_number] => 06774141 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Calanolide and related antiviral compounds, compositions, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/083249 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 17193 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774141.pdf [firstpage_image] =>[orig_patent_app_number] => 09083249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1136433 [patent_doc_number] => 06780421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Adjuvant for a vaccine composition' [patent_app_type] => B1 [patent_app_number] => 08/836576 [patent_app_country] => US [patent_app_date] => 1997-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 3929 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780421.pdf [firstpage_image] =>[orig_patent_app_number] => 08836576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802123 [patent_doc_number] => 20020010132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => ' COMPOSITIONS OF MURAMYL PEPTIDES INHIBITING THE REPLICATION OF HIV\n ' [patent_app_type] => original-publication-amended [patent_app_number] => 08/809650 [patent_app_country] => US [patent_app_date] => 1997-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 2045 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010132.pdf [firstpage_image] =>[orig_patent_app_number] => 08809650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730994 [patent_doc_number] => 20030187184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'ANTIGENICALLY REACTIVE REGIONS OF THE HEPATITIS A VIRUS POLYPROTEIN' [patent_app_type] => new [patent_app_number] => 09/171432 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20578 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187184.pdf [firstpage_image] =>[orig_patent_app_number] => 09171432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690344 [patent_doc_number] => 07074616 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-11 [patent_title] => 'Mouse CXC chemokine receptor' [patent_app_type] => utility [patent_app_number] => 09/367052 [patent_app_country] => US [patent_app_date] => 1997-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 14030 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074616.pdf [firstpage_image] =>[orig_patent_app_number] => 09367052 [rel_patent_id] =>[rel_patent_doc_number] =>)